CClinicalTrials.gg
CompletedNCT00637299Updated Oct 24, 2011Results posted

Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial

An Early Phase 1 interventional study of Active osteopathic treatment (OMT+PR): Active Comparator and sham osteopathic treatment (SOT+PR) in Chronic Obstructive Pulmonary Disease, sponsored by Fondazione Salvatore Maugeri. Completed at 1 site in Italy. Open to participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2011-10-24.

Sponsored by Fondazione Salvatore Maugeri · Early Phase 1, Interventional, and Supportive care

Phase
Early Phase 1
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
All
01

Study summary

The purpose of this trial is to verify if an osteopathic treatment added to usual pulmonary rehabilitation trial is able to improve the walking ability of COPD patients and if there is any influence on lung functionality.

Read the detailed description

The investigators decided to perform an osteopathic manipulative treatment (OMT) in a population of COPD patients. OMT was defined as the therapeutic application of manually guided forces by an osteopathic practitioner to improve physiologic function and/or support homeostasis that has been altered by somatic dysfunction. Concerning the respiratory system, osteopathy considers a model that describes the interdependent functions among five body components as follows: 1: the inherent motility of the brain and spinal cord; 2: fluctuation of the cerebrospinal fluid; 3: mobility of the intracranial and intraspinal membranes; 4: articular mobility of the cranial bones; 5: the involuntary mobility of the sacrum between the ilia. This model is the so called primary respiratory mechanism.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 20 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Fondazione Salvatore Maugeri is the lead sponsor of 23 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • patients affected by COPD

Exclusion criteria

Exclusion Criteria:

  • other diseases other than COPD
05

Study design

Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Active comparator
    Active osteopathic treatment (OMT+PR)

    The examination was performed by osteopathic practitioners with emphasis on the neuromusculoskeletal system including palpatory diagnosis for somatic dysfunction and viscerosomatic change, in the context of total patient care. The examination was concerned with range of motion of all parts of the body, performed with the patient in multiple positions to provide static and dynamic evaluation.

    Other: Active osteopathic treatment (OMT+PR): Active Comparator

  • Sham comparator
    SOT + PR

    Sham osteopathic treatment (manipulation)

    Other: sham osteopathic treatment (SOT+PR)

Interventions

  • OtherActive osteopathic treatment (OMT+PR): Active Comparator

    The treatment was done once a week for 4 weeks and lasted 30 minutes.The examination was done according to the following scheme: anamnesis; physical examination (evaluation of the posture, palpation, tests for passive and active motion of areas linked to altered respiratory function); cranic-sacral evaluation (by means of a palpation of the cranic-sacral mechanism).

    Also known as: OMT+PR

  • Othersham osteopathic treatment (SOT+PR)

    Only soft manipulation was performed

    Also known as: SOT+PR

06

What researchers measure

Primary outcomes

  1. Walking Ability

    6 minutes walking test (6MWT)

    Time frame: 4 weeks

Secondary outcomes

  1. Lung Function Test

    residual volume (RV)

    Time frame: 4 weeks

07

Results

Posted Apr 20, 2009

Participant flow

Participant flow — Overall Study
MilestoneActive Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryWalking Ability

6 minutes walking test (6MWT)

Time frame:
4 weeks
Reported as:
Mean · meters
Walking Ability
metersActive Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)
Walking Ability369.5 ± 80304.7 ± 96.6
Statistical analysis
  • Active Osteopathic Treatment vs Sham Osteopathic Treatment (Manipulation) · t-test, 1 sided · p = <0.01
SecondaryLung Function Test

residual volume (RV)

Time frame:
4 weeks
Reported as:
Mean · liters
Lung Function Test
litersActive Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)
Lung Function Test3.09 ± 1.74.23 ± 1.4
Statistical analysis
  • Active Osteopathic Treatment vs Sham Osteopathic Treatment (Manipulation) · t-test, 1 sided · p = <0.05

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Active Osteopathic Treatment———
Sham Osteopathic Treatment (Manipulation)———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Active Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)Total
<=18 years000
Between 18 and 65 years8412
>=65 years268
Age Continuous
Age Continuous(years)Active Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)Total
Mean64.2 ± 5.563.5 ± 4.763.8 ± 5.1
Sex: Female, Male
Sex: Female, Male(Participants)Active Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)Total
Female235
Male8715
Region of Enrollment
Region of Enrollment(participants)Active Osteopathic TreatmentSham Osteopathic Treatment (Manipulation)Total
Italy101020
08

Study locations

1 site
  • Fondazione Salvatore Maugeri
    Montescano, Pavia 27040, Italy
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 24, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00637299
Lead sponsor
Fondazione Salvatore Maugeri
Responsible party
Ercole Zanotti (MD, Fondazione Salvatore Maugeri) — Principal investigator
First posted
Mar 17, 2008
Start date
Jan 2008
Primary completion
Jul 2008
Completion
Nov 2008
Results posted
Apr 20, 2009
Last update
Oct 24, 2011

Study contacts

Ercole Zanotti, md
principal investigator · Fondazione Salvatore Maugeri

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion